SWX:NOVNPharmaceuticals
Is Novartis (SWX:NOVN) Still Undervalued After Its Recent Share Price Strength?
Novartis (SWX:NOVN) has been grinding higher, with shares up around 7 % over the past month and nearly 30 % over the past year, as investors lean into its steady earnings and pipeline story.
See our latest analysis for Novartis.
That move has been underpinned by solid execution rather than hype, with the roughly 30 % one year total shareholder return riding a clear uptrend in the share price as investors warm to its growth and defensiveness.
If Novartis has you rethinking your healthcare...